author-photo

Maria Theodoulou

Memorial Sloan Kettering Cancer Center

55

Papers

2666

Citations

Citation Trend

Filter By

Papers (45) Sort By

Journal Conference Others

A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review

2016
Show All
- Source
- Cite
- Save
Citations (8)
Preclinical testing of a novel regimen of capecitabine (C) in combination with bevacizumab (B) and trastuzumab (T) in a breast cancer xenograft model

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (27)
Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P2-16-07: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P5-18-20: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer.

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (18)
Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)